Showing items 1641-1665 of 1933 (78 Page(s) Totally)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T04:04:37Z |
Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril
|
Chu, T.S.;Wu, M.S.;Chen, Y.M.;Wu, K.D.; TZONG-SHINN CHU |
| 臺大學術典藏 |
2018-09-10T03:41:11Z |
Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide
|
Wu, K.-D.;Liao, T.-S.;Chen, Y.-M.;Lai, M.-K.;Chen, S.-I.;Su, C.-T.;Chu, T.-S.;Chang, C.-C.;Hsieh, B.-S.; TZONG-SHINN CHU |
| 臺大學術典藏 |
2018-09-10T03:41:11Z |
Exaggerated natriuresis in primary aldosteronism.
|
Chen, Y.M.;Hsieh, B.S.;Wu, K.D.;Chu, T.S.; TZONG-SHINN CHU |
| 臺大學術典藏 |
2018-09-10T03:41:10Z |
Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD
|
Cheng, S.C.;Chu, T.S.;Huang, K.Y.;Chen, Y.M.;Chang, W.K.;Tsai, T.J.;Wu, K.D.; TZONG-SHINN CHU |
| 臺大學術典藏 |
2018-09-10T03:30:52Z |
Endothelin-1 chronically inhibits Na/H exchanger-3 in ET(B)-overexpressing OKP cells
|
Chu, T.-S.;Wu, K.-D.;Wu, M.-S.;Hsieh, B.-S.; TZONG-SHINN CHU; MING-SHIOU WU |
| 臺大學術典藏 |
2018-09-10T03:23:25Z |
Exaggerated natriuresis in salt-sensitive essential hypertension
|
Wu, K.-D.;Hsieh, B.-S.;Tsai, H.-F.;Chen, Y.-M.;Chu, T.-S.; TZONG-SHINN CHU |
| 臺大學術典藏 |
2018 |
Primary aldosteronism and cerebrovascular diseases
|
KAO-LANG LIU; Wang S.-M.; Huang K.-H.; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D.; Hu F.-C.; Lin L.-Y.; Wu C.-H.; Chang H.-W.; Lin Y.-H.; Wu V.-C.; Hung C.-S.; Chen Z.-W.; Chen Z.-W.;Hung C.-S.;Wu V.-C.;Lin Y.-H.;Wu C.-H.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Kao-Lang Liu;Wang S.-M.;Huang K.-H.;Chen Y.-M.;Chang C.-C.;Liao S.-C.;Yen R.-F.;Wu K.-D. |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
RUOH-FANG YEN; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Tsai Y.-C.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Chan C.-K.; Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Huang K.-H.;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Ruoh-Fang Yen |
| 臺大學術典藏 |
2018 |
Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors
|
Wu C.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu C.-J.; Wu K.-D.; National Taiwan University Study Group on Acute Renal Failure; Lin J.-H.; Shiao C.-C.; Wang W.-J.; Chen C.-Y.; Chang Y.-H.; Wang J.-J.; Chen Y.-M.; Chu T.-S.; Huang T.-M.; Lai C.-F.; Lin Y.-F.; Tsai I.-J.; Lai T.-S.; Chen L.; Wu C.-J.; Huang T.-M.; Chen H.-H.; Lin Y.-F.; Pan C.-F.; Lin C.-S.; Chen C.-Y.; Lin C.-J. |
| 臺大學術典藏 |
2018 |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
YEN-HUNG LIN; Huang K.-H.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2018 |
MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas
|
Chueh S.-C.J.; Yang S.-Y.; Huang K.-H.; YEN-HUNG LIN; Wu V.-C.; Wu K.-D.; Chan C.-K.; Chang C.-H.; Lin Y.-F.; Chang H.-M.; Peng K.-Y. |
| 臺大學術典藏 |
2018 |
Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors
|
Lin J.-H.; Wang W.-J.; Shiao C.-C.; Chang Y.-H.; Chen C.-Y.; Wang J.-J.; Chen Y.-M.; Chu T.-S.; Huang T.-M.; Lai C.-F.; Chen C.-Y.;Vin-Cent Wu;Lin C.-J.;Lin C.-S.;Pan C.-F.;Chen H.-H.;Lin Y.-F.;Huang T.-M.;Chen L.;Wu C.-J.;Vin-Cent Wu;Lai T.-S.;Lin Y.-F.;Tsai I.-J.;Lai C.-F.;Huang T.-M.;Chu T.-S.;Chen Y.-M.;Wang J.-J.;Chang Y.-H.;Chen C.-Y.;Shiao C.-C.;Wang W.-J.;Lin J.-H.;Wu C.-H.;Yeh Y.-C.;Lai C.-H.;Tseng L.-J.;Wu C.-J.;Wu K.-D.;National Taiwan University Study Group On Acute Renal Failure; Chen C.-Y.; VIN-CENT WU; Lin C.-J.; Lin C.-S.; Pan C.-F.; Chen H.-H.; Lin Y.-F.; Huang T.-M.; Chen L.; Wu C.-J.; VIN-CENT WU; Lai T.-S.; Lin Y.-F.; Tsai I.-J.; Wu C.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu C.-J.; Wu K.-D.; National Taiwan University Study Group on Acute Renal Failure |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Huang K.-H.;Lin Y.-H.;Vin-Cent Wu;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Yen R.-F.; Yen R.-F.; Lu C.-C.; Liao S.-C.; Hu F.-C.; Wang S.-M.; Lin L.-Y.; Chang H.-W.; Yu C.-C.; Tsai Y.-C.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; VIN-CENT WU; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L. |
| 臺大學術典藏 |
2018 |
MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas
|
Chan C.-K.; Lin Y.-F.; Chang H.-M.; Peng K.-Y.; Peng K.-Y.;Chang H.-M.;Lin Y.-F.;Chan C.-K.;Chang C.-H.;Chueh S.-C.J.;Shao-Yu Yang;Huang K.-H.;Lin Y.-H.;Wu V.-C.;Wu K.-D.; Chang C.-H.; Chueh S.-C.J.; SHAO-YU YANG; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D. |
| 臺大學術典藏 |
2018 |
Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors
|
Chen C.-Y.; Wu V.-C.; Lin C.-J.; Lin C.-S.; Pan C.-F.; Chen H.-H.; Lin Y.-F.; Huang T.-M.; Chen L.; Wu C.-J.; Wu V.-C.; TAI-SHUAN LAI; Lin Y.-F.; Tsai I.-J.; Lai C.-F.; Huang T.-M.; Chu T.-S.; Chen Y.-M.; Wang J.-J.; Chang Y.-H.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu C.-J.; Wu K.-D.; National Taiwan University Study Group on Acute Renal Failure |
| 臺大學術典藏 |
2018 |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; TAI-SHUAN LAI; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2018 |
New-onset diabetes after acute kidney injury requiring dialysis
|
Chu T.-S.; Wu V.-C.; Chen L.; TAI-SHUAN LAI; Yang S.-Y.; Huang T.-M.; Lin S.-L.; Lin Y.-F.; Wu K.-D. |
| 臺大學術典藏 |
2017 |
Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury
|
Huang T.-M.; Pan S.-Y.; Chang C.-H.; Lai C.-F.; Wu V.-C.; Wu M.-S.; Wu K.-D.; Chu T.-S.; Lin S.-L.; YU-HSIANG CHOU; Yu-Hsiang Chou;Huang T.-M.;Pan S.-Y.;Chang C.-H.;Lai C.-F.;Wu V.-C.;Wu M.-S.;Wu K.-D.;Chu T.-S.;Lin S.-L. |
| 臺大學術典藏 |
2017 |
Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study
|
Chueh S.-C.J.; Wu K.-D.; Chen L.; Chang Y.-S.; Lin P.-C.; Chu T.-S.; Kao T.-W.; Lin Y.-H.; Wang C.-Y.; Chang C.-H. |
| 臺大學術典藏 |
2017 |
Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Wang T.-D.; Wang C.-Y.; Tu S.T.; Jeff Chueh S.-C.; Tseng F.-Y.; Wu K.-D.; Wang W.-J.; Wu C.-H.; Ho Y.-L.; Lin L.-Y.; Hu Y.-H.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Liao S.-C.; TAIPAI group; Lin Y.-H.; Lin J.-H.; Wu V.-C.; Hu Y.-H.; Er L.K.; Yen R.-F.; Chang C.-H.; Chang Y.-L.; CHING-CHU LU; Chang C.-C. |
| 臺大學術典藏 |
2017 |
Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years
|
Wu V.-C.; Chueh S.-C.J.; Chen L.; Chang C.-H.; Hu Y.-H.; YEN-HUNG LIN; Wu K.-D.; Yang W.-S. |
| 臺大學術典藏 |
2017 |
Corrigendum: Long term outcome of Aldosteronism after target treatments
|
Wu K.-D.; Wu V.-C.; Wang S.-M.; Chang C.-H.; Hu Y.-H.; Lin L.-Y.; YEN-HUNG LIN; Chueh S.-C.J.; Chen L. |
| 臺大學術典藏 |
2017 |
The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: A hypothesis generating pilot study
|
The NRPB Kidney Consortium; Wu K.-D.; YEN-HUNG LIN; Yang S.-Y.; Wu V.-C.; Wu C.-H.; Yang Y.-W.; Huang K.-H.; Chang C.-H. |
| 臺大學術典藏 |
2017 |
Perioperative body weight change is associated with in-hospital mortality in cardiac surgical patients with postoperative acute kidney injury
|
Shiao C.-C.;Huang Y.-T.;Lai T.-S.;Huang T.-M.;Wang J.-J.;Huang C.-T.;Wu P.-C.;Wu C.-H.;Tsai I.-J.;Tseng L.-J.;Wang C.-H.;Chu T.-S.;Wu K.-D.;Vin-Cent Wu;National Taiwan University Hospital Study Group On Acute Renal Failure (Nsarf); Shiao C.-C.; Huang Y.-T.; Lai T.-S.; Huang T.-M.; Wang J.-J.; Huang C.-T.; Wu P.-C.; Wu C.-H.; Tsai I.-J.; Tseng L.-J.; Wang C.-H.; Chu T.-S.; Wu K.-D.; VIN-CENT WU; National Taiwan University Hospital Study Group on Acute Renal Failure (NSARF) |
Showing items 1641-1665 of 1933 (78 Page(s) Totally)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
View [10|25|50] records per page
